Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Chicago › NPI 1982292777
Lab

Alcoa Validations INC

Alcoa Validations INC was paid $133K by Medicaid between Aug 2022 and Mar 2023, across 5 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 45% of everything it billed.

33Billing provider infoALCOA VALIDATIONS INC
CHICAGO, IL 60642
33aNPI1982292777assigned 01/06/2021
28Total paid$133K
24GClaims3,536
24DCodes billed5
24AFirst – last monthAug 2022 – Mar 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#116 of 235
Median peer was paid$123K
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20223,320$133K
2023216$297.60
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 45% 807 683 $59K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 25% 812 711 $33K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 15% 899 763 $21K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 15% 802 680 $20K
K1034 Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count <1% 216 179 $297.60

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJOHNSON, CHRISTOPHER (MANAGING DIRECTOR)
Same official

Other billing entities under JOHNSON, CHRISTOPHER

Full network →
ProviderLocationPaid
Imagine Kids Dentistry PLLCFountain, CO$829K
Eyecare Associates of West Richland, LLPWest Richland, WA$452K
Christopher D. Johnson Od, PCDallas, OR$94K
Christopher R. Johnson, M.D., P.A.Athens, TX$66K
C Johnson INCMilaca, MN$17K
Vancouver Guidance ClinicVancouver, WA$3K
Hillside DentalEau Claire, WI$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.